Luca Valenti
Luca Valenti
Associate Professor of Internal Medicine, UniversitÓ degli Studi di Milano, Fondazione Ca' Granda
Verified email at unimi.it
Title
Cited by
Cited by
Year
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes
AL Fracanzani, L Valenti, E Bugianesi, M Andreoletti, A Colli, E Vanni, ...
Hepatology 48 (3), 792-798, 2008
6392008
Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes
D Frescas, L Valenti, D Accili
Journal of Biological Chemistry 280 (21), 20589-20595, 2005
5432005
Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease
L Valenti, A Al‐Serri, AK Daly, E Galmozzi, R Rametta, P Dongiovanni, ...
Hepatology 51 (4), 1209-1217, 2010
4822010
Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease
L Valenti, AL Fracanzani, P Dongiovanni, G Santorelli, A Branchi, E Taioli, ...
Gastroenterology 122 (2), 274-280, 2002
3762002
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
P Dongiovanni, S Petta, C Maglio, AL Fracanzani, R Pipitone, E Mozzi, ...
Hepatology 61 (2), 506-514, 2015
2892015
Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis
S Fargion, M Mattioli, AL Fracanzani, M Sampietro, D Tavazzi, P Fociani, ...
The American journal of gastroenterology 96 (8), 2448-2455, 2001
2842001
Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study
L Valenti, AL Fracanzani, P Dongiovanni, E Bugianesi, G Marchesini, ...
American Journal of Gastroenterology 102 (6), 1251-1258, 2007
2772007
Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target
P Dongiovanni, AL Fracanzani, S Fargion, L Valenti
Journal of hepatology 55 (4), 920-932, 2011
2542011
Carotid artery intima-media thickness in nonalcoholic fatty liver disease
AL Fracanzani, L Burdick, S Raselli, P Pedotti, L Grigore, G Santorelli, ...
The American journal of medicine 121 (1), 72-78, 2008
2512008
Patatin‐like phospholipase domain‐containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C
L Valenti, MG Rumi, E Galmozzi, A Aghemo, B Del Menico, S De Nicola, ...
Hepatology 53 (3), 791-799, 2011
2472011
I148M patatin‐like phospholipase domain‐containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease
L Valenti, A Alisi, E Galmozzi, A Bartuli, B Del Menico, A Alterio, ...
Hepatology 52 (4), 1274-1280, 2010
2432010
The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent
RM Mancina, P Dongiovanni, S Petta, P Pingitore, M Meroni, R Rametta, ...
Gastroenterology 150 (5), 1219-1230. e6, 2016
2402016
HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease
L Valenti, AL Fracanzani, E Bugianesi, P Dongiovanni, E Galmozzi, ...
Gastroenterology 138 (3), 905-912, 2010
2292010
Statin use and non-alcoholic steatohepatitis in at risk individuals
P Dongiovanni, S Petta, V Mannisto, RM Mancina, R Pipitone, V Karja, ...
Journal of hepatology 63 (3), 705-712, 2015
2252015
Genetics and epigenetics of NAFLD and NASH: clinical impact
M Eslam, L Valenti, S Romeo
Journal of hepatology 68 (2), 268-279, 2018
2152018
PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells
C Pirazzi, L Valenti, BM Motta, P Pingitore, K Hedfalk, RM Mancina, ...
Human molecular genetics 23 (15), 4077-4085, 2014
2042014
Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta‐analysis of individual participant data
E TrÚpo, P Nahon, G Bontempi, L Valenti, E Falleti, HD Nischalke, ...
Hepatology 59 (6), 2170-2177, 2014
1802014
Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease
P Dongiovanni, L Valenti, R Rametta, AK Daly, V Nobili, E Mozzi, ...
Gut 59 (2), 267-273, 2010
1592010
A 360-degree overview of paediatric NAFLD: recent insights
V Nobili, G Svegliati-Baroni, A Alisi, L Miele, L Valenti, P Vajro
Journal of hepatology 58 (6), 1218-1229, 2013
1532013
Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment
P Dongiovanni, Q M Anstee, L Valenti
Current pharmaceutical design 19 (29), 5219-5238, 2013
1522013
The system can't perform the operation now. Try again later.
Articles 1–20